Leptin Is a Negative Independent Predictor of Areal BMD and Cortical Bone Size in Young Adult Swedish Men
- 1 December 2006
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 21 (12) , 1871-1878
Abstract
The association between leptin and areal BMD has been controversial, and the predictive role of leptin on cortical volumetric BMD and bone size has not previously been studied. We show that leptin is a negative independent predictor of aBMD (DXA), at several measured sites, and of cortical bone size (pQCT) in a large population of young men. Introduction: Recent findings suggest that both adipose tissue (AT) and bone mass are regulated by leptin. Previous reports studying the association between leptin and areal BMD (aBMD) have yielded conflicting results. The role of leptin on volumetric BMD (vBMD) and bone size of the cortical and trabecular bone compartments has not previously been studied. Materials and Methods: The Gothenburg Osteoporosis and Obesity Determinants (GOOD) study is a population-based study of 1068 men (age, 18.9 ± 0.6 [SD] years). aBMD of the total body, lumbar spine, femoral neck, both radii, and trochanter, as well as total body AT and lean mass (LM) were measured using DXA, whereas cortical and trabecular vBMD and bone size were measured by pQCT. Results: Total body LM could explain a larger magnitude of the difference in the variation in aBMD and cortical bone size than what total body AT could (total body aBMD: LM 37.4% versus AT 8.7%; tibia cross-sectional area [CSA]: LM 46.8% versus AT 5.6%). The independent role of leptin on bone parameters was studied using a multiple linear regression model, including age, total body LM and AT, height, present physical activity, calcium intake, and smoking as covariates. Leptin was found to be a negative independent predictor of aBMD (total body: β =−0.08, p =0.01; lumbar spine: β =−0.13, p < 0.01; trochanter: β =−0.09, p =0.01), as well as of the cortical bone size (CSA and thickness) of both the radius (CSA: β =−0.12, p < 0.001) and tibia (CSA: β =−0.08, p < 0.01), but not of the cortical or trabecular vBMD of these bones. Conclusion: Our results indicate that LM has a greater impact on bone mass than AT. Our findings further show that leptin is a negative independent predictor of aBMD at several measured sites and of bone parameters reflecting cortical bone size, but not vBMD, in a large population of young Swedish men.Keywords
This publication has 41 references indexed in Scilit:
- Association of Amount of Physical Activity With Cortical Bone Size and Trabecular Volumetric BMD in Young Adult Men: The GOOD StudyJournal of Bone and Mineral Research, 2005
- Free Testosterone Is a Positive, Whereas Free Estradiol Is a Negative, Predictor of Cortical Bone Size in Young Swedish Men: The GOOD StudyJournal of Bone and Mineral Research, 2005
- Age of Attainment of Peak Bone Mass Is Site Specific in Swedish Men—The GOOD StudyJournal of Bone and Mineral Research, 2005
- Males Have Larger Skeletal Size and Bone Mass Than Females, Despite Comparable Body SizeJournal of Bone and Mineral Research, 2005
- SERUM LEPTIN VALUES IN RELATION TO BONE DENSITY AND GROWTH HORMONE-INSULIN LIKE GROWTH FACTORS AXIS IN HEALTHY MENArchives of Andrology, 2004
- Relationships among body mass, its components, and bone11Published simultaneously at BoneKEy-Osteovision (http://www.bonekey-ibms.org), a Web site sponsored by the International Bone and Mineral Society.Bone, 2002
- Association between bone mineral density (DXA), body structure, and body composition in middle‐aged menAmerican Journal of Human Biology, 2002
- Relationship of Serum Leptin Concentration With Bone Mineral Density in the United States PopulationJournal of Bone and Mineral Research, 2002
- Leptin Inhibits Bone Formation through a Hypothalamic RelayCell, 2000
- Correlates of bone mineral density in the postmenopausal estrogen/progestin interventions trialJournal of Bone and Mineral Research, 1994